STOCK TITAN

Microvast faces Nasdaq notice over sub-$1 share price

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Microvast Holdings, Inc. (MVST) disclosed that on August 26, 2026 it received a notice from Nasdaq that its common stock failed to meet the $1.00 minimum closing bid price requirement under Nasdaq Listing Rule 5450(a)(1), after trading below that level for the last 30 consecutive trading days. The notice does not immediately affect trading and the shares remain listed, but will be flagged as non-compliant. Microvast has 180 days to regain compliance and plans to monitor its share price and explore options to restore compliance. If it cannot do so within the grace period (or any additional period it may qualify for), Nasdaq is expected to move toward delisting, which Microvast could then appeal to a Nasdaq Hearings Panel, during which time trading would typically continue.

Positive

  • None.

Negative

  • Nasdaq bid-price deficiency raises delisting risk: MVST’s stock has traded below $1.00 for 30 consecutive trading days, triggering a Nasdaq notice and a 180‑day cure period, after which the shares may be delisted if compliance is not regained or relief is not granted.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Minimum closing bid price requirement $1.00 per share Nasdaq Listing Rule 5450(a)(1) requirement for continued listing
Non-compliance measurement period 30 consecutive trading days Period during which MVST’s average closing bid was below $1.00
Initial grace period to cure deficiency 180 days Time allowed for MVST to regain compliance with the minimum bid price rule
Nasdaq Listing Rule 5450(a)(1) regulatory
"as required for continued listing on the Nasdaq under Rule 5450(a)(1)"
Nasdaq Listing Rule 5450(a)(1) is a continued-listing standard that sets a minimum share price companies must maintain to remain listed on the Nasdaq market—commonly a $1.00 per-share threshold. Investors care because falling below that floor can trigger a compliance review and possible delisting, which is like failing a minimum grade and losing access to the public market; delisting can reduce liquidity, visibility and the ability to raise capital.
minimum closing bid price market
"was below the minimum closing bid price of $1 per share"
A minimum closing bid price is the lowest share price a stock must register at market close—often set by an exchange or regulator and sometimes measured over a series of days—to keep the stock listed. Think of it like a minimum score a team must maintain to stay in a league; falling below it can trigger warnings, delisting risk, or corporate fixes such as reverse stock splits, and so it matters because it affects liquidity, investor access and the value and tradability of shares.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Nasdaq Hearings Panel regulatory
"the Company may appeal such determination to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
forward-looking statements regulatory
"includes “forward-looking statements” within the meaning of the safe harbor"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

Why did Microvast (MVST) receive a Nasdaq non-compliance notice?

Microvast received a Nasdaq notice because its common stock’s average closing bid price was below $1.00 per share for the last 30 consecutive trading days, violating the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1).

Is Microvast (MVST) being delisted from Nasdaq now?

No. The notice has no immediate impact on Microvast’s listing. The stock will continue trading on Nasdaq, though marked as non-compliant, while the company works within the 180‑day grace period to regain compliance.

How long does Microvast (MVST) have to regain Nasdaq bid-price compliance?

Microvast has 180 days under Nasdaq’s rules to cure the minimum $1.00 bid price deficiency and regain compliance, with the possibility of additional time periods if it becomes eligible for them.

What happens if Microvast (MVST) does not regain compliance within 180 days?

If Microvast does not regain the minimum $1.00 bid price compliance within the 180‑day period (or any additional eligible period), Nasdaq is expected to notify the company that its common stock is subject to delisting from Nasdaq.

Can Microvast (MVST) appeal a potential Nasdaq delisting?

Yes. If Nasdaq moves to delist the stock, Microvast may appeal to a Nasdaq Hearings Panel. The company expects its common stock would remain listed and tradable on Nasdaq at least during the appeal process.

What actions does Microvast (MVST) plan in response to the Nasdaq notice?

Microvast states it intends to monitor the closing bid price of its common stock and explore available options to regain compliance with Nasdaq’s minimum bid price rule within the allowed period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001760689 0001760689 2026-08-26 2026-08-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 26, 2026

 

Microvast Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38826   83-2530757
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS. Employer
Identification No.)

2929 Briarpark Drive, Suite 400

HoustonTexas 77042

(Address of principal executive offices, including zip code)

 

281-491-9505

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.0001 per share   MVST   The NASDAQ Stock Market LLC
 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 
 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On August 26, 2026, Microvast Holdings, Inc. (the “Company”) received written notice from the NASDAQ Stock Market LLC (“Nasdaq”) notifying it that the average closing bid price of the Company’s shares of common stock, par value $0.0001 per share (the “Common Stock”) was below the minimum closing bid price of $1 per share during the last 30 consecutive trading days, as required for continued listing on the Nasdaq under Rule 5450(a)(1) of Nasdaq’s listing rules (the “Rules”).

 

The notice has no immediate impact on the listing of the Common Stock, which will continue to be listed and trade on Nasdaq subject to the Company’s continued compliance with the other listing requirements of the Rules. The Company’s Common Stock will have an added indicator on NASDAQ.com indicating that it is currently non-compliant. Pursuant to the Rules, the Company has 180 days to cure the deficiency and regain compliance with the minimum closing bid price (subject to additional time periods for which the Company may be eligible). The Company intends to monitor the closing bid price for the Common Stock and explore available options to regain compliance within the prescribed time period.

 

In the event the Company does not evidence compliance with the minimum closing bid price requirement during the 180-day grace period (or any additional time period for which the Company may be eligible), it is expected that Nasdaq would notify the Company that the shares of Common Stock are subject to delisting. At such time, the Company may appeal such determination to a Nasdaq Hearings Panel (the “Panel”) and it is expected that the Company’s shares of Common Stock would continue to be listed and available to trade on Nasdaq at least pending the completion of the appeal process. There can be no assurance that any such appeal would be successful or that the Company would be able to evidence compliance with the terms of any extension that may be granted by the Panel.

 

This Current Report is filed to satisfy the obligation under Nasdaq Listing Rule 5810(b) and Item 3.01(a) of Form 8-K that the Company make a public announcement disclosing the deficiency no later than four business days from the date of the Notice.

 

Forward Looking Statements

 

This Current Report on Form 8-K includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “expects,” “intends,” “will,” “would” or other similar expressions. Such statements are subject to certain risks and uncertainties that may cause the Company’s actual results to differ from the expectations expressed in the forward-looking statements. There can be no assurance that the Company will achieve such expectations, including regaining compliance with the minimum closing bid price rule during any compliance period or in the future, otherwise meeting Nasdaq compliance standards, being granted by Nasdaq any relief from delisting as necessary, or ultimately meeting applicable Nasdaq requirements for any such relief. For a discussion of the risks and uncertainties that may cause the Company’s actual results to differ from the expectations expressed in these forward-looking statements, please see the Risk Factors sections included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 and any future filings we make with the Securities and Exchange Commission. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

 

 

 

 

 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                 
Date: August 31, 2026 MICROVAST HOLDINGS, INC.
   
  By: /s/ Rodney Worthen
  Name: Rodney Worthen
  Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Filing Exhibits & Attachments

3 documents